RESUMEN

Introduction: Pharmaceutical Intervention aims to optimize and rationalize the use, effectiveness, and safety of dispensed medications resolving drug-related problems (DRPs) and negative medicine outcomes (NMOs). Objectives: To evaluate Pharmaceutical Interventions in Benzodiazepines users during the COVID-19 pandemic from a Community Pharmacy. Method: Prospective observational, descriptive, and cross-sectional study (AEMPS code: DAA-CLO-2020-01) of Pharmaceutical Interventions offered by the community pharmacy between August 2020 and February 2021. Results: A total of 306 Pharmaceutical Interventions were conducted involving 127 patients. Health education and personalized medication information were the most common Pharmaceutical Interventions after detecting a high level of unfamiliarity with the Benzodiazepines among patients. Pharmaceutical Interventions leading to medical referrals accounted for 37.8% of the total, triggered by the detection of DRPs and/or NMOs or after identifying the patient as candidate for deprescription. These referrals included patients with a very high level of depression according to the Euroqol 5D-3L test. Pharmaceutical Interventions resulting in Medication Review with Follow-up Service were performed in 3.1% of patients. The patient acceptance rate of Pharmaceutical Interventions reached 98.4%. Conclusions: The high acceptance rate of Pharmaceutical Interventions reinforces the value of Community Pharmacy in optimizing and rationalizing Benzodiazepines usage, while strengthening the pharmacist-patient relationship. The COVID-19 pandemic posed challenges to pharmacist-physician collaboration despite of the availability of telecommunication protocols among healthcare professionals.

RESUMEN

BACKGROUND: Tolerance and dependence stand out as the most relevant risks observed during benzodiazepine (BZD) treatments. OBJECTIVES: To evaluate the degree of dependence of patients on BZD treatments using the Tyrer test; to define a profile of patients at risk of developing BZD dependence; and to discuss the role of the pharmaceutical care offered by the community pharmacy during dispensing. METHODS: Prospective cross-sectional descriptive observational study (August 2020-February 2021) involving 127 patients using BZD. They voluntarily answered a questionnaire during the dispensing pharmaceutical care service. The study was evaluated and codified (code: DAA-CLO-2020-01) by the Spanish Agency for Drugs and Health Products (AEMPS), and statistical analysis was performed with SPSS 25.0. RESULTS: 19.05% of patients using BZD were suspected of suffering from BZD tolerance, and 77.88% of all patients were identified as being at a high risk of BZD dependence. The Tyrer test for dependence indicated a mean score of 5.59 out of 13 points. An 18-fold increased risk of developing dependence was detected in the case of coexistence of high anxiety or depression. CONCLUSIONS: The community pharmacy, through protocolized care practices and supported by tools such as the Tyrer test, can play a decisive role in the detection, prevention, and resolution of the risks associated with BZD treatments.

RESUMEN

Introducción: El estudio y análisis del uso prolongado de Benzodiacepinas (BZD) sigue siendo un objetivo estratégicopara todos los niveles asistenciales y en especial para la Atención Farmacéutica. Los cuestionarios como herramientade investigación científica proporcionan una escala de medición que permite evaluar y comparar individuos conparámetros de fiabilidad y validez. Objetivo: Diseñar un cuestionario de recogida de datos (CDR) que permita la personalización de la dispensación deBZD según las características de los usuarios. Método: Revisión bibliográfica de las evidencias científicas existentes con expertos en Atención Farmacéutica, diseñode la encuesta e implementación piloto (pre-testing) del CRD con usuarios de BZD, y depuración de los ítems y formatode éstos a incluir en el CDR final. Resultados: El CDR diseñado y distribuido en 8 dimensiones, abarca parámetros sociodemográficos, de conocimientode la medicación, el test de adherencia Morisky-Green, la mediación de calidad de vida por Euroqol 5D3L y escala visualEVA, el test de Pfeiffer para deterioro cognitivo, el test de dependencia a BZD, la opción de registro de la intervención farmacéutica realizada y aceptación de la misma por parte del usuario y el grado de satisfacción del paciente sobre laintervención. Conclusiones: El CDR es un innovador instrumento práctico transferible a la práctica asistencial que permite caracterizaral paciente usuario de BZD en el momento de la dispensación en la farmacia comunitaria permitiendo individualizar ysistematizar la intervención farmacéutica al tiempo que fomentar el uso seguro y eficaz de la BZD por parte del paciente.(AU)

Introduction: The study and analysis of the prolonged use of Benzodiazepines (BZD) remains a strategic objective forall levels of care and especially for Pharmaceutical Care. Questionnaires as a scientific research tool provide ameasurement scale that allows the evaluation and comparison of individuals with parameters of reliability and validity. Objective: To design a data collection questionnaire (CDR) that allows the personalization of BZD dispensing accordingto the characteristics of the usersMethods: Bibliographic review of existing scientific evidence with experts in Pharmaceutical Care, design of the surveyand pilot implementation (pre-testing) of the CRD with BZD users, and refinement of the items and their format to beincluded in the final CDR. Results: The CDR designed and distributed in 8 dimensions, covers socio-demographic parameters, knowledge ofmedication, the Morisky-Green adherence test, quality of life mediation by Euroqol 5D3L and EVA visual scale, the Pfeiffertest for cognitive impairment, the BZD dependence test, the option of recording the pharmaceutical intervention carriedout and its acceptance by the user and the degree of patient satisfaction with the interventionConclusions: The CDR is an innovative practical tool that can be transferred to healthcare practice, allowing the patientto characterize the BZD user at the time of dispensing in the community pharmacy, enabling the individualization andsystematization of the pharmaceutical intervention while promoting the safe and effective use of the BZD by the patient.(AU)

Asunto(s)

RESUMEN

Introducción: los registros clínicos de enfermería se realizan de acuerdo con las normas establecidas y conforme a la estructura del modelo del cuidado, de lo contrario se incurre en omisión. Objetivo: evaluar el cumplimiento del registro clínico electrónico acorde al modelo del cuidado de enfermería. Metodología: estudio transversal, retrospectivo, documental. El universo constó de los registros que realizó el personal de enfermería en el expediente electrónico. La muestra fue de 1658 expedientes. Resultados: El cumplimiento del registro clínico electrónico fue de 69%. Hubo mayor cumplimiento en el turno matutino (75%) y en hospitalización (74%). Indicadores como fortaleza y debilidad fueron habitus exterior (95%) y consulta de planes de cuidado de enfermería y guías de práctica clínica (15%). Conclusión: El nivel de cumplimiento del registro clínico electrónico permite intervenir sobre las áreas de oportunidad identificadas y fortalecer el apego a modelos del cuidado.

Introduction: Nursing clinical records are made according to the established norms and according to the structure of the care model, otherwise there is an omission. Objective: To evaluate compliance with the electronic clinical record according to the nursing care model. Methods: Cross-sectional, retrospective, documentary study. Universe: records made by the nursing staff in the electronic file. Sample n = 1658 files. Results: Compliance with the electronic clinical record was 69%. There was greater compliance in the morning shift with 75% and hospitalization 74%. Indicators such as strength and weakness were outward habits (95%) and consultation of nursing care plans and clinical practice guidelines (15%). Conclusion: The level of compliance with the electronic clinical record allows to intervene in areas of opportunity and strengthen adherence to models of care.

Asunto(s)